| Stage | MDT | % of rev | CNMD | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $9.8B | 100.00% | $336M | 100.00% | MDT ×29.07 |
| Gross profit | $6.3B | 64.99% | $189M | 56.37% | MDT +8.6pp |
| Operating income | $1.8B | 18.08% | $37M | 11.07% | MDT +7.0pp |
| Pre-tax income | $1.8B | 18.13% | $26M | 7.75% | MDT +10.4pp |
| Net income | $1.5B | 15.16% | $20M | 5.90% | MDT +9.3pp |
| Stage | MDT | CNMD | Gap · A − B |
|---|---|---|---|
| Revenue | $9.8B100.00% | $336M100.00% | MDT ×29.07 |
| Gross profit | 64.99%$6.3B | 56.37%$189M | MDT +8.6pp |
| Operating income | 18.08%$1.8B | 11.07%$37M | MDT +7.0pp |
| Pre-tax income | 18.13%$1.8B | 7.75%$26M | MDT +10.4pp |
| Net income |
| 15.16%$1.5B |
| 5.90%$20M |
| MDT +9.3pp |
No shared counterparties.